Five things for pharma marketers to know: Friday, May 6, 2016

Five things for pharma marketers to know: Friday, May 6, 2016

Investigation says Oxycontin wears off sooner than it claims; PBMs and insurers anticipate high biosimilar prices; Valeant forms pricing committee

An emotional bond with patients is key, says Elemental Machines' Iyengar

An emotional bond with patients is key, says Elemental Machines' Iyengar

At the MM&M Transforming Healthcare conference, Iyengar told attendees how to take into account a consumer's behavior and emotion when marketing medical products.

Care Angel wins MM&M Shark Tank challenge 2016

Care Angel wins MM&M Shark Tank challenge 2016

The Siri for Seniors took the top prize at the second MM&M Shark Tank for its annual healthcare conference.

Omnicom to acquire BioPharm Communications

Omnicom to acquire BioPharm Communications

Omnicom recently reorganized its health agencies under the Omnicom Health Group umbrella.

Five things for pharma marketers to know: Thursday, May 5, 2016

Five things for pharma marketers to know: Thursday, May 5, 2016

U.S. Keytruda sales miss mark; the CDC warns parents to try therapy before drugs for children with ADHD; FDA panel recommends training for opioid prescribers

Time is running out: Fill in MM&M's Agency questionnaire

Time is running out: Fill in MM&M's Agency questionnaire

Did your agency report record growth in 2015? Tell us why when you fill out the A-to-Z questionnaire for MM&M's upcoming agency issue. The deadline is Friday.

Five things for pharma marketers to know: Wednesday, May 4, 2016

Five things for pharma marketers to know: Wednesday, May 4, 2016

The FDA issues warning for certain antipsychotics; Shkreli may face more securities charges; Genentech and Stand Up to Cancer launch campaign

Five things for pharma marketers to know: Tuesday, May 3, 2016

Five things for pharma marketers to know: Tuesday, May 3, 2016

IMS and Quintiles to merge and create $17 billion firm; Biogen spins off hemophilia company; Google partners with the National Health Service

Five things for pharma marketers to know: Monday, May 2, 2016

Five things for pharma marketers to know: Monday, May 2, 2016

Express Scripts to roll out pricing response program; the FDA approves new Parkinson's disease treatment; Regeneron's plaque psoriasis drug hits endpoint

Five things for pharma marketers to know: Friday, April 29, 2016

Five things for pharma marketers to know: Friday, April 29, 2016

Harvoni and Sovaldi growth begins to slow; drugmakers spend billions to buy developers of cancer therapies; Valeant discloses new investigations

OPINION


Click here to learn about the Agency Issue. 

Email Newsletters